Tina Ventura | Senior Vice President, Chief Investor Relations Officer |
Tim Walbert | Chairman, President and Chief Executive Officer |
Elizabeth Thompson | Executive Vice President, Research & Development |
Aaron Cox | Executive Vice President and Chief Financial Officer |
Andy Pasternak | Executive Vice President, Chief Strategy Officer |
Chris Schott | J.P. Morgan |
Ken Cacciatore | Cowen and Company, LLC |
David Amsellem | Piper Sandler |
Annabel Samimy | Stifel, Nicolaus & Company, Inc. |
Michael Ulz | Morgan Stanley |
Robert Palermo | Goldman Sachs |
Jason Gerberry | Bank of America |
Amy Li | Jefferies LLC |
Derek Archila | Wells Fargo Securities |
Gary Nachman | BMO Capital Markets Corp. |
Good morning and thank you for standing by. Welcome to the Horizon Therapeutics plc Second Quarter 2022 Earnings Conference Call.
As a reminder, today's conference call is being recorded. I would now like to introduce Ms. Tina Ventura, Senior Vice President and Chief Investor Relations Officer.